Perioperative Continuous Glucose Monitoring Accuracy in Cardiac Surgery
ConditionCardiac Surgery
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age19+
SponsorSeoul National University Hospital
About this trial
The goal of this clinical trial is to evaluate accuracy of continuous glucose monitoring device called 'Dexcom G7' in patients undergoing cardiac surgery.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients aged 19 years or older scheduled for cardiac surgery
Disqualifiers
Skin disease at the sensor application site (proximal arm)
Trial population
Patients who scheduled for cardiac surgery in Seoul National University Hospital
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Dexcom G7
DeviceContinuous glucose monitoring device (Dexcom G7) will be applied to patients undergoing cardiac surgery intraoperatively and postoperatively (maximum 10 days)
Treatment groups
100 Participants
are divided into 1 treatment groupGroup A: CGM cohort1 intervention
Trial outcomes
Primary outcomes
1
MARD
mean absolute relative difference
Time frame
From the beginning of operation to the end of postoperative ICU stay (maximum 10 days)Secondary outcomes
1
Bland-Altman analysis
mean difference, bias, 95% limits of agreement
Time frame
From the beginning of operation to the end of postoperative ICU stay (maximum 10 days)2
ISO criteria
Satisfaction of 2013 ISO (International Organization of Standardization) criteria
Time frame
From the beginning of operation to the end of postoperative ICU stay (maximum 10 days)3
DTS error grid
DTS (Diabtetes Technology Society) error grid
Time frame
From the beginning of operation to the end of postoperative ICU stay (maximum 10 days)Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov